DNL628
DNLI-K-0001
Phase 1 small_molecule active
Quick answer
DNL628 for Alzheimer Disease, Early Onset is a Phase 1 program (small_molecule) at Denali Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Denali Therapeutics
- Indication
- Alzheimer Disease, Early Onset
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active